Adam David DeVore, MD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Clinical Research Institute 2400 Pratt Street, Np-8064, Durham, NC 27705
Phone (919) 668-8788
Email address adam.devore@duke.edu

Adam D. DeVore, MD, MHS

Dr. DeVore is a cardiologist and Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include heart failure, including the care of patients with left ventricular assist devices and heart transplants. He is involved in and leads many studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute.

The overarching goal of his research is to improve the outcomes and quality of life of patients with heart failure. This includes both advancing the current understanding of heart failure through clinical trials as well as developing an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. Dr. DeVore published the first trial conducted within the Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He is also interested in implementation projects for new heart failure therapeutics, including using pragmatic study designs and registry-based randomized trials to improve the translation of evidence-based care into clinical practice. He is currently the faculty clinical lead for the American Heart Association’s Get With The Guidelines-Heart Failure registry as well as the CHAnge the Management of Patients with Heart Failure (CHAMP-HF) registry. He is also the principal investigator for Care Optimization through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF), a large-scale, pragmatic, cluster-randomized trial at 160 sites in the US evaluating heart failure quality improvement initiatives.

Dr. DeVore is also the medical director for the Heart Failure Research Cluster at Duke University Medical Center. He is well-published in many high impact journals and is the author of multiple book chapters and editorials. He also serves as a reviewer for many cardiovascular and heart failure-specific journals.

In Their Words

Education and Training

  • Fellowship in Advanced Heart Failure, Medicine, Duke University School of Medicine, 2015 - 2016
  • Fellowship in Clinical Research, DCRI, Duke University School of Medicine, 2013 - 2015
  • Fellowship in Cardiovascular Medicine, Medicine, Duke University School of Medicine, 2011 - 2013
  • Internal Medicine Residency, Brigham and Women's Hospital, 2007 - 2010
  • M.D., University of Chicago, 2007

Publications

Lyons, Kristin J., Justin A. Ezekowitz, Li Liang, Paul A. Heidenreich, Clyde W. Yancy, Adam D. DeVore, Adrian F. Hernandez, and Gregg C. Fonarow. “Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy..” Jacc Heart Fail 5, no. 5 (May 2017): 388–92. https://doi.org/10.1016/j.jchf.2017.02.018.

PMID
28449799
Full Text

Ambardekar, A. V., J. Thibodeau, A. DeVore, M. Kittleson, R. Fbrde-McLean, M. Palardy, M. Mountis, et al. “Slow Gait Speed Linked to More Severe Disease but Not with Early Events in Ambulatory Advanced Heart Failure: Results from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.” In Journal of Heart and Lung Transplantation, 36:S179–S179. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Ambardekar, V., M. Kittleson, M. Palardy, M. Mountis, R. Forde-McLean, A. DeVore, S. Pamboukian, et al. “Advanced Therapy Utilization and Survival in Ambulatory Patients with Advanced Heart Failure: Results from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.” In Journal of Heart and Lung Transplantation, 36:S193–S193. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Pagani, F., M. Kittleson, G. Stewart, A. DeVore, M. Brinkley, S. Myers, M. Miller, D. Naftel, J. J. Teuteberg, and L. W. Stevenson. “Glad to Have a VAD Across Intermacs Profiles.” In Journal of Heart and Lung Transplantation, 36:S196–S196. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Ambrosy, Andrew P., Lukasz P. Cerbin, Adam D. DeVore, Stephen J. Greene, William E. Kraus, Christopher M. O’Connor, Ileana L. Piña, et al. “Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial..” Am Heart J 186 (April 2017): 130–38. https://doi.org/10.1016/j.ahj.2016.12.017.

PMID
28454828
Full Text

Fonarow, Gregg C., Nancy Albert, Javed Butler, J Herb Patterson, John Spertus, Fredonia Williams, Stuart Turner, et al. “HEART FAILURE WITH REDUCED EJECTION FRACTION CARE PATTERNS IN THE OUTPATIENT PRACTICE SETTING: INITIAL FINDINGS FROM CHAMP-HF.” In Journal of the American College of Cardiology, 69:701–701. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Jalnapurkar, Sawan, Xin Zhao, Paul Heidenreich, Deepak Bhatt, Eric Smith, Adam DeVore, Adrian Hernandez, Roland Matsouaka, Clyde Yancy, and Gregg Fonarow. “A HOSPITAL LEVEL ANALYSIS OF 30-DAY READMISSION RATES FOR HEART FAILURE PATIENTS AND LONG-TERM SURVIVAL AMONG HIGHEST AND LOWEST PERFORMING HOSPITALS, FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE.” In Journal of the American College of Cardiology, 69:2565–2565. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Cooper, Lauren Beth, Lina Benson, Robert Mentz, Gianluigi Savarese, Adam DeVore, Juan Jesus Carrero, Ulf Dahlstrom, et al. “ASSOCIATION BETWEEN SERUM POTASSIUM LEVEL AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A COHORT STUDY FROM THE SWEDISH HEART FAILURE REGISTRY.” In Journal of the American College of Cardiology, 69:678–678. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Greene, Stephen, G Michael Felker, Jie Sun, Andrew Ambrosy, Bradley Bart, Javed Butler, Adam DeVore, et al. “HEMOCONCENTRATION DURING MANAGEMENT OF PATIENTS WITH ACUTE HEART FAILURE AND CARDIORENAL SYNDROME: INSIGHTS FROM CARRESS-HF.” In Journal of the American College of Cardiology, 69:767–767. ELSEVIER SCIENCE INC, 2017.

Scholars@Duke

Pun, Patrick H., Shubin Sheng, Gillian Sanders, Adam D. DeVore, Daniel Friedman, Gregg C. Fonarow, Paul A. Heidenreich, Clyde W. Yancy, Adrian F. Hernandez, and Sana M. Al-Khatib. “Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function..” Am J Cardiol 119, no. 6 (March 15, 2017): 886–92. https://doi.org/10.1016/j.amjcard.2016.11.043.

PMID
28160975
Full Text

Pages